Package 62332-423-05

{"route": ["TOPICAL"], "spl_id": "ef882383-ae44-4dcc-a0fd-6e3ee971b57f", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0362332423057"], "unii": ["X4HES1O11F"], "rxcui": ["141859"], "spl_set_id": ["878615c2-09ea-44ce-8c30-7a7f16acb20c"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (62332-423-05)  / 5 g in 1 TUBE", "package_ndc": "62332-423-05", "marketing_start_date": "20231127"}], "brand_name": "ACYCLOVIR", "product_id": "62332-423_ef882383-ae44-4dcc-a0fd-6e3ee971b57f", "dosage_form": "CREAM", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "62332-423", "generic_name": "ACYCLOVIR", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ACYCLOVIR", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "50 mg/g"}], "application_number": "ANDA212361", "marketing_category": "ANDA", "marketing_start_date": "20231127", "listing_expiration_date": "20261231"}